GPC1 is overexpressed in human pancreatic cancer cells [14], breast cancer cells [15], and gliomas [16], and it increases the proliferative response to FGF2, heparin-binding epidermal growth factor-like growth factor (HBEGF), and HGF. This evidence concerns the gene GPC1 and pancreatic neoplasm.